Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome

Critical Care Medicine

Volumn 34, Issue 11, 2006, Pages 2749-2757

  Forel, Jean Marie ^a   Roch, Antoine ^a   Marin, Valérie ^a   Michelet, Pierre ^a   Demory, Didier ^a   Blache, Jean Louis ^b   Perrin, Gilles ^a   Gainnier, Marc ^a   Bongrand, Pierre ^a   Papazian, Laurent ^a  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b INSTITUT PAOLI CALMETTES   (France)

Author keywords

Acute respiratory distress syndrome; Cytokines; Inflammation mediators; Mechanical ventilation; Neuromuscular blocking agents; Oxygenation

Indexed keywords

CISATRACURIUM; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NEUROMUSCULAR BLOCKING AGENT; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ARTIFICIAL VENTILATION; BLOOD SAMPLING; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; LUNG LAVAGE; LUNG PRESSURE; MALE; MULTICENTER STUDY; NEUROMUSCULAR BLOCKING; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; TIDAL VOLUME; TREATMENT OUTCOME;

CYTOKINES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKING AGENTS; OXYGEN; POSITIVE-PRESSURE RESPIRATION; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 33750279268     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000239435.87433.0D     Document Type: Article

References (56)

1. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000; 342:1334-1349
2. Bernard GR, Artigas A, Brigham KL, et al: The American-European Consensus Conference on ARDS: Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818-824
3. Donnelly SC, Strieter RM, Kunkel SL, et al: Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993; 341:643-647
4. Goodman RB, Pugin J, Lee JS, et al: Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev 2003; 14:523-535
5. Martin TR: Lung cytokines and ARDS: Roger S. Mitchell Lecture. Chest 1999; 116:2S-8S
6. Pugin J, Verghese G, Widmer MC, et al: The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med 1999; 27:304-312
7. Pugin J, Ricou B, Steinberg KP, et al: Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med 1996; 153:1850-1856
8. Artigas A, Bernard GR, Carlet J, et al: The American-European Consensus Conference on ARDS: Part 2. Ventilatory, pharmacologic, supportive therapy, study design strategies and issues related to recovery and remodeling. Intensive Care Med 1998; 24:378-398
9. Dreyfuss D, Soler P, Basset G, et al: High inflation pressure pulmonary edema: Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 1988; 137:1159-1164
10. Dreyfuss D, Saumon G: Ventilator-induced lung injury: Lessons from experimental studies. Am J Respir Crit Care Med 1998; 157:294-323
11. Corbridge TC, Wood LD, Crawford GP, et al: Adverse effects of large tidal volume and low PEEP in canine acid aspiration. Am Rev Respir Dis 1990; 142:311-315
12. Pinhu L, Whitehead T, Evans T, et al: Ventilator-associated lung injury. Lancet 2003; 361:332-340
13. Parker JC, Townsley MI, Rippe B, et al: Increased microvascular permeability in dog lungs due to high peak airway pressures. J Appl Physiol 1984; 57:1809-1816
14. Muscedere JG, Mullen JB, Gan K, et al: Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit Care Med 1994; 149:1327-1334
15. Rouby JJ, Lherm T, Martin de Lassale E, et al: Histologic aspects of pulmonary barotrauma in critically ill patients with acute respiratory failure. Intensive Care Med 1993; 19:383-389
16. Tremblay L, Valenza F, Ribeiro SP, et al: Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 1997; 99:944-952
17. Ranieri VM, Suter PM, Tortorella C, et al: Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: A randomized controlled trial. JAMA 1999; 282:54-61
18. Chiumello D, Pristine G, Slutsky AS: Mechanical ventilation affects local and systemic cytokines in an animal model of acute respiratory distress syndrome. Am J Respir Crit Care Med 1999; 160:109-116
19. Von Bethmann AN, Brasch F, Nusing R, et al: Hyperventilation induces release of cytokines from perfused mouse lung. Am J Respir Crit Care Med 1998; 157:263-272
20. Tutor JD, Mason CM, Dobard E, et al: Loss of compartmentalization of alveolar tumor necrosis factor after lung injury. Am J Respir Crit Care Med 1994; 149:1107-1111
21. Tremblay LN, Slutsky AS: Ventilator-induced injury: From barotrauma to biotrauma. Proc Assoc Am Physicians 1998; 110:482-488
22. The Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-1308
23. Parsons PE, Eisner MD, Thompson BT, et al: Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005; 33:1-6; discussion, 230-232
24. Hunter JM: New neuromuscular blocking drugs. N Engl J Med 1995; 332:1691-1699
25. Murray MJ, Cowen J, DeBlock H, et al: Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 2002; 30:142-156
26. Gainnier M, Roch A, Forel JM, et al: Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Crit Care Med 2004; 32:113-119
27. Ramsay MA, Savege TM, Simpson BR, et al: Controlled sedation with alphaxalone-alphadolone. BMJ 1974; 2:656-659
28. Hollenberg SM, Ahrens TS, Astiz ME, et al: Task Force of the American College of Critical Care Medicine: Practice parameters for hemodynamic support of sepsis in adult patients. Crit Care Med 1999; 27:639-660
29. Dargaville PA, South M, Vervaart P, et al: Validity of markers of dilution in small volume lung lavage. Am J Respir Crit Care Med 1999; 160:778-784
30. Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957-2963
31. Murray JF, Matthay MA, Luce JM, et al: An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138:720-723
32. Steinberg JM, Schiller HJ, Halter JM, et al: Alveolar instability causes early ventilator-induced lung injury independent of neutrophils. Am J Respir Crit Care Med 2004; 169:57-63
33. Valenza F, Guglielmi M, Irace M, et al: Positive end-expiratory pressure delays the progression of lung injury during ventilator strategies involving high airway pressure and lung overdistention. Crit Care Med 2003; 31:1993-1998
34. Laffey JG, Tanaka M, Engelberts D, et al: Therapeutic hypercapnia reduces pulmonary and systemic injury following in vivo lung reperfusion. Am J Respir Crit Care Med 2000; 162:2287-2294
35. Imai Y, Parodo J, Kajikawa O, et al: Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. JAMA 2003; 289:2104-2112
36. Mead J, Takishima T, Leith D: Stress distribution in lungs: A model of pulmonary elasticity. J Appl Physiol 1970; 28:596-608
37. Cheng KC, Zhang H, Lin CY, et al: Ventilation with negative airway pressure induces a cytokine response in isolated mouse lung. Anesth Analg 2002; 94:1577-1582
38. Pedersen BK, Hoffman-Goetz L: Exercise and the immune system: Regulation, integration, and adaptation. Physiol Rev 2000; 80:1055-1081
39. Vassilakopoulos T, Roussos C, Zakynthinos S: The immune response to resistive breathing. Eur Respir J 2004; 24:1033-1043
40. Mukaida N: Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol 2003; 284:566-577
41. Van Otteren GM, Standiford TJ, Kunkel SL, et al: Alterations of ambient oxygen tension modulate the expression of tumor necrosis factor and macrophage inflammatory protein-1 alpha from murine alveolar macrophages. Am J Respir Cell Mol Biol 1995; 13:399-409
42. Krabbe KS, Pedersen M, Bruunsgaard H: Inflammatory mediators in the elderly. Exp Gerontol 2004; 39:687-699
43. Brismar B, Hedenstierna G, Lundquist H, et al: Pulmonary densities during anesthesia with muscular relaxation: A proposal of atelectasis. Anesthesiology 1985; 62:422-428
44. Hedenstierna G, Strandberg A, Brismar B, et al: Functional residual capacity, thoracoabdominal dimensions, and central blood volume during general anesthesia with muscle paralysis and mechanical ventilation. Anesthesiology 1985; 62:247-254
45. Rothen HU, Sporre B, Engberg G, et al: Reexpansion of atelectasis during general anaesthesia: A computed tomography study. Br J Anaesth 1993; 71:788-795
46. Tokics L, Hedenstierna G, Svensson L, et al: V/Q distribution and correlation to atelectasis in anesthetized paralyzed humans. J Appl Physiol 1996; 81:1822-1833
47. Hubmayr RD, Abel MD, Rehder K: Physiologic approach to mechanical ventilation. Crit Care Med 1990; 18:103-113
48. Coggeshall JW, Marini JJ, Newman JH: Improved oxygenation after muscle relaxation in adult respiratory distress syndrome. Arch Intern Med 1985; 145:1718-1720
49. Manthous CA, Hall JB, Kushner R, et al: The effect of mechanical ventilation on oxygen consumption in critically ill patients. Am J Respir Crit Care Med 1995; 151:210-214
50. Freebairn RC, Derrick J, Gomersall CD, et al: Oxygen delivery, oxygen consumption, and gastric intramucosal pH are not improved by a computer-controlled, closed-loop, vecuronium infusion in severe sepsis and septic shock. Crit Care Med 1997; 25:72-77
51. Conti G, Vilardi V, Rocco M, et al: Paralysis has no effect on chest wall and respiratory system mechanics of mechanically ventilated, sedated patients. Intensive Care Med 1995; 21:808-812
52. Putensen C, Leon MA, Putensen-Himmer G: Effect of neuromuscular blockade on the elastic properties of the lungs, thorax, and total respiratory system in anesthetized pigs. Crit Care Med 1994; 22:1976-1980
53. Hund E: Myopathy in critically ill patients. Crit Care Med 1999; 27:2544-2547
54. Hansen-Flaschen J, Cowen J, Raps EC: Neuromuscular blockade in the intensive care unit: More than we bargained for. Am Rev Respir Dis 1993; 147:234-236
55. Imai Y, Kawano T, Miyasaka K, et al: Inflammatory chemical mediators during conventional ventilation and during high frequency oscillatory ventilation. Am J Respir Crit Care Med 1994; 150:1550-1554
56. Slutsky AS, Tremblay LN: Multiple system organ failure: Is mechanical ventilation a contributing factor? Am J Respir Crit Care Med 1998; 157:1721-1725